You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 135 No. 6, June 1975 TABLE OF CONTENTS
  Archives
  •  Online Features
  CLINICAL NOTES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Hyperinsulinemic Hypoglycemia Associated With a Neurofibrosarcoma

Santokh S. Lyall, MD; Norman J. Marieb, MD; Jonathan K. Wise, MD; John L. Cornog, MD; Edwin C. Neville, MD; Philip Felig, MD

Arch Intern Med. 1975;135(6):865-867.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Hypoglycemia associated with extrapancreatic tumors is a well known but uncommon phenomenon. The types of tumors associated with hypoglycemia are generally of mesodermal origin (fibrosarcoma, neurofibroma, mesothelioma) but are occasionally endodermal in origin (hepatoma, adrenal carcinoma, renal carcinoma).1 Various mechanisms regarding the pathogenesis of tumor hypoglycemia have been postulated, including production of insulin or an insulin-like substance by the tumor, consumption of glucose by the tumor mass, or production of a polypeptide or amino acid, particularly tryptophan, causing inhibition of gluconeogenesis.1-3 Early studies involving nonspecific bioassay techniques demonstrated an increase in "insulin-like activity" in plasma, tumor tissue, or both.4,5 However, subsequent studies employing the specific immunoassay technique described by Yalow and Berson6 have failed repeatedly to provide evidence of hyperinsulinemia associated with extrapancreatic tumor hypoglycemia.5,7-9 Oleesky et al10 described hyperinsulinemic hypoglycemia in a patient with a retroperitoneal fibrosarcoma, but their data consisted of a single determination of immunoreactive insulin. In . . . [Full Text PDF of this Article]


Author Affiliations

From the Hospital of St. Raphael and the Department of Internal Medicine, Yale University School of Medicine, New Haven, Conn.


Footnotes

Received for publication July 17, 1974; accepted Oct 10.

Reprint requests to 333 Cedar St, New Haven, CT 06510 (Dr. Felig).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1975 American Medical Association. All Rights Reserved.